Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Conduct Disorder, Aggression
Interventions: Lithium, Placebo; Drug
Lead sponsor: Drexel University; Other
Eligibility: 9 Years to 17 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2005
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Autism Spectrum Disorder, Autism
Interventions: GuessWhat Mobile Application; Other
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Intellectual Disability, Developmental Disability
Interventions: Written language intervention; Behavioral
Lead sponsor: Baylor University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Waco, Texas

Conditions: Autism Spectrum Disorder
Interventions: GWP42006; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 4 Years to 18 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 3
States / cities: Louisville, Kentucky • Lexington, Massachusetts • Columbus, Ohio

Conditions: Autism Spectrum Disorder, Insomnia Chronic, Caregiver Burden
Interventions: Cognitive behavioral therapy for Insomnia; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 3 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Amphetamine, ESDM informed parent coaching, Placebo Oral Tablet; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 36 Months to 131 Months
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: ADHD, Sleep Problems
Interventions: Ferrous Sulfate, Placebo; Dietary Supplement · Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 8 Years to 18 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Generalized Anxiety Disorder (GAD), Anxiety, Separation, Phobia, Social
Interventions: SPD503 (extended-release Guanfacine hydrochloride), Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 33
States / cities: Birmingham, Alabama • Carson, California • Imperial, California + 29 more

Conditions: Anxiety Disorders, Separation Anxiety Disorder, Phobic Disorders
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 13 Years to 17 Years
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Cerebral Palsy, Myelomeningocele, Arthrogryposis, Motor Skills Disorders, Gross Motor Development Delay
Interventions: adapted Chicago Run running program; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 6 Years to 18 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Chicago Heights, Illinois

Conditions: Canavan Disease
Interventions: Not listed
Lead sponsor: Aspa Therapeutics; Industry
Eligibility: Not listed
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Oakland, California • Boston, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: I2-ART, Usual care; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autism, Sleep Disturbance
Interventions: Power Down bedtime manipulation; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 6 Years to 10 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Anesthesia, Neurotoxicity, Child Development
Interventions: Sevoflurane, Remifentanil, Dexmedetomidine; Drug
Lead sponsor: Murdoch Childrens Research Institute; Other
Eligibility: Up to 2 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 5
States / cities: Boston, Massachusetts • Cleveland, Ohio • Philadelphia, Pennsylvania + 2 more

Conditions: Autism Spectrum Disorder
Interventions: Usability assessment of Cognoa ASD Therapeutic Device; Device
Lead sponsor: Cognoa, Inc.; Industry
Eligibility: 3 Years to 8 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Obsessive-Compulsive Disorder in Children, Social Anxiety Disorder of Childhood, Obsessive-Compulsive Disorder in Adolescence, Separation Anxiety, Generalized Anxiety Disorder, Panic Disorder, Panic Attacks, Panic With Agoraphobia
Interventions: Standard SPACE, Bibliotherapy, low therapist contact SPACE; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 7 Years to 17 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Epilepsy, Cerebral Palsy, Developmental Delay
Interventions: Dexmedetomidine bolus and high infusion-Propofol, Dexmedetomidine bolus and low infusion-Propofol, Dexmedetomidine bolus only - Propofol; Drug
Lead sponsor: Joseph Cravero; Other
Eligibility: 1 Year to 12 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: L-theanine, Caffeine, L-theanine-Caffeine Combination, Placebo; Dietary Supplement · Other
Lead sponsor: Texas Tech University; Other
Eligibility: 8 Years to 17 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Music-Based Binaural Beats Stimulation, Music Listening Without Binaural Beats; Behavioral
Lead sponsor: California State University, San Bernardino; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Bernardino, California

Conditions: Autism Spectrum Disorder
Interventions: Not listed
Lead sponsor: Stalicla SA; Industry
Eligibility: 4 Years to 10 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: AR11, Placebo; Drug
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 7
States / cities: Bradenton, Florida • Maitland, Florida • South Miami, Florida + 3 more

Conditions: Autism
Interventions: Behavioral Assessment; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 5 Years to 18 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Leukodystrophy, White Matter Disease, Leukoencephalopathies, 4H Syndrome, Adrenoleukodystrophy, AMN, ALD, ALD Gene Mutation, ALD (Adrenoleukodystrophy), X-linked Adrenoleukodystrophy, X-ALD, Adrenomyeloneuropathy, Aicardi Goutieres Syndrome, AGS, Alexander Disease, Alexanders Leukodystrophy, AxD, ADLD, Canavan Disease, CTX, Cerebrotendinous Xanthomatoses, Krabbe Disease, GALC Deficiency, Globoid Leukodystrophy, TUBB4A-Related Leukodystrophy, H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum, HBSL, HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity, LBSL, Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation, ALSP, CSF1R Gene Mutation, HCC - Hypomyelination and Congenital Cataract, MLC1, Megalencephalic Leukoencephalopathy With Subcortical Cysts, MLD, Metachromatic Leukodystrophy, PMD, Pelizaeus-Merzbacher Disease, PLP1 Null Syndrome, PLP1 Gene Duplication &#X7C; Blood or Tissue &#X7C; Mutations, Pelizaeus Merzbacher Like Disease, Peroxisomal Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Salla Disease, Sialic Storage Disease, Sjögren, Sjogren-Larsson Syndrome, Van Der Knapp Disease, Vanishing White Matter Disease, Charcot-Marie-Tooth, CMT, Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency, Allan-Herndon-Dudley Syndrome, Cadasil, Cockayne Syndrome, Multiple Sulfatase Deficiency, Gangliosidoses, GM2 Gangliosidosis, BPAN, Labrune Syndrome, LCC, Mucopolysaccharidoses, TBCK-Related Intellectual Disability Syndrome
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Not listed
Enrollment: 12,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2030
U.S. locations: 23
States / cities: Los Angeles, California • Orange, California • Palo Alto, California + 18 more

Conditions: Attention Deficit Disorder With Hyperactivity, Marijuana Abuse
Interventions: Atomoxetine, placebo; Drug · Other
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 14 Years to 21 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Long-Term Lithium Treatment for Aggressive Conduct Disorder

Piloting a Mobile Game for Behavioral Therapy

Written Language Intervention for Adults With Intellectual and Developmental Disabilities

Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder

Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism

Impact of Combined Medication and Behavioral Treatment for ASD & ADHD

A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions

Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility Challenges

Natural History Study of Patients With Canavan Disease (CANinform Study)

Family Navigation to Improve ADHD Treatment Adherence for Minority Children

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

A Study to Compare the Long-term Outcomes After Two Different Anaesthetics

Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study

Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder

A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

Effects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Children With Attention Deficit Hyperactivity Disorder

Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder

Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.

The Myelin Disorders Biorepository Project

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder